Results 101 to 110 of about 510,668 (221)

21st Century Cardio-Oncology

JACC: Basic to Translational Science, 2016
Cardiotoxicity is a well-established complication of oncology therapies. Cardiomyopathy resulting from anthracyclines is a classic example. In the past decade, an explosion of novel cancer therapies, often targeted and more specific than conventional ...
Calvin Chen Sheng, MD, Laleh Amiri-Kordestani, MD, Todd Palmby, PhD, Thomas Force, MD, Charles C. Hong, MD, PhD, Joseph C. Wu, MD, PhD, Kevin Croce, MD, PhD, Geoffrey Kim, MD, Javid Moslehi, MD   +8 more
doaj   +1 more source

Association of altered body composition with cardiac wasting in cancer with and without cardiotoxic therapy

British Journal of Pharmacology, EarlyView.
Created in BioRender: Scientific Figure and Illustration Software. Background and Purpose In advanced cancer, associations among changes in body composition, cardiac wasting and prior cardiotoxic anticancer therapy have not been investigated. Experimental Approach Using bioelectrical impedance analysis (BIA), body composition was measured in 206 ...
Sara Hadzibegovic, Jonathan L. Hella, Jan Porthun, Alessia Lena, Danara Krug, Iulia Baluta, Ursula Wilkenshoff, Amir A. Mahabadi, Matthias Totzeck, Tienush Rassaf, Stefan D. Anker, Wolfram Doehner, Ulrich Keller, Lars Bullinger, Dominik P. Modest, Barry J. A. Laird, Richard J. E. Skipworth, John G. F. Cleland, Christian Oeing, Stephan von Haehling, Ulf Landmesser, Markus S. Anker   +21 more
wiley   +1 more source

Evaluating the efficacy of large language models in cardio-oncology patient education: a comparative analysis of accuracy, readability, and prompt engineering strategies

Frontiers in Artificial Intelligence
BackgroundThe integration of large language models (LLMs) into cardio-oncology patient education holds promise for addressing the critical gap in accessible, accurate, and patient-friendly information.
Zhao Wang, Lin Liang, Hao Xu, Yuhui Huang, Chen He, Weiran Xu, Haojie Zhu   +6 more
doaj   +1 more source

Metabolic remodelling in anthracycline cardiotoxicity: mechanisms and therapeutic insights

British Journal of Pharmacology, EarlyView.
Cardiac metabolic remodelling in anthracycline‐induced cardiomyopathy and metabolically oriented cardioprotective strategies. Schematic representation of substrate utilization, mitochondrial bioenergetic function and metabolic flexibility in the healthy heart, in anthracycline‐induced cardiomyopathy and under potential cardioprotective interventions ...
Giulia Guerra, Francesco Niro, Marco Mergiotti, Giovanni Gavatorta, Emilio Hirsch, Alessandra Ghigo   +5 more
wiley   +1 more source

Understanding cardio-oncology and potential impacts on patients

, 2022
Cardio-oncology is a new multidisciplinary field that involves the management of cardiovascular side effects in patients receiving anti-cancer therapies . Recent advances in clinical oncology resulted in an increased number of anti-cancer drugs that have
Booth, Carl, Kobat, Hasan, Nabhani-Gebara, Shereen   +2 more
core  

Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions

Clinical Endocrinology, EarlyView.
ABSTRACT Objective To provide clinicians involved in managing menopause with a summary of current evidence surrounding menopause hormone therapy (MHT). Design The authors evaluate and synthesize existing pooled evidence relating to MHT's clinical indications, efficacy, and safety and explore the limitations of existing data. Patients The review focuses
Annice Mukherjee, Susan R. Davis
wiley   +1 more source

Building Bridges in Cardio-Oncology: The Role of Clinics in Multidisciplinary Care and Patient Outcomes

Indonesian Journal of Cancer
Cardio-oncology is a specialized field within cardiology that focuses on the relationship between cancer, its therapies, and cardiovascular health. This multidisciplinary domain, involving cardiology, hematology, and oncology, addresses the significant ...
Sidhi Laksono
doaj   +1 more source

Validation of Cardiorespiratory‐Gated Proton Beam Delivery for Stereotactic Arrhythmia Radioablation

Journal of Cardiovascular Electrophysiology, EarlyView.
Stereotactic arrhythmia radioablation (STAR) with scanned proton beams was performed in a porcine model targeting the left ventricular free wall (A). Dual gating synchronized proton delivery with both respiratory and cardiac motion was compared to single gating using only respiratory motion (B).
Jagdip Kang, Felicitas J. Bijari, Yanis Chemli, Yen‐Lin Chen, Helen Deng, Nicolas Depauw, Maeva Dhaynaut, Adriano Garonna, Hyeongseok Kim, Marina Macdonald‐Soccorso, Sung‐Hyun Moon, Marc D. Normandin, Rebecca Woodcock, K. Moshe Yaghoubian, Georges El Fakhri, Robert Levine, Kyung‐Wook Jee, H. Immo Lehmann   +17 more
wiley   +1 more source

Cardio-oncology: what you need to know now for clinical practice and echocardiography

Echo Research and Practice, 2017
Cardio-oncology is a rapidly growing field aimed at minimizing the effects of cardiovascular morbidity and mortality in cancer survivors. To meet this aim, patients are assessed at baseline to define their risk of cardiotoxicity and then followed closely
Carolyn M Larsen, Sharon L Mulvagh
doaj   +1 more source

Standardizing the Clinical Approach to Cancer Therapy‐Related Cardiac Dysfunction: Applying Cardio‐Oncology Guidelines as a Practical Tool for Hematology and Oncology Providers

Cancer Medicine
Introduction and Methods Cancer therapy–related cardiac dysfunction (CTRCD) is a well established and potentially life‐threatening complication of contemporary oncologic treatment.
Abdelrahman Ali, Suparna C. Clasen, Anne Blaes, Stephen Casselli, Anita Deswal, Susan Halli Demeter, Gregory Durm, Anecita Fadol, Alessandra Ferrajoli, Michael G. Fradley, Joerg Herrmann, Borja Ibanez, Sue Koob, Bogda Koczwara, Kasey J. Leger, Jennifer E. Liu, Teresa López‐Fernández, Alexander R. Lyon, N. G. Choon Ta, John Teerlink, Eric H. Yang, Susan Dent, Daniel Lenihan   +22 more
doaj   +1 more source